Health Minister Nadda chairs MedTech CEO roundtable

Union Health and Family Welfare and Chemicals and Fertilizers Minister J.P. The discussions also covered the policy and regulatory measures required to make India a competitive hub for medical device development and manufacturing.

Nadda also released a knowledge paper titled “AI in MedTech: Revolutionizing Healthcare Through Artificial Intelligence”, which outlines a roadmap for accelerating responsible adoption of artificial intelligence in India’s healthcare and medical device sector. The report, jointly developed by Praxis Global Alliance and FICCI, examines.

What Happened

The report identifies five key priorities for accelerating AI adoption in India’s medical technology sector. It describes MedTech as one of the country’s most immediate and scalable opportunities for AI, with the potential to embed specialist expertise directly into medical devices and.

• Nadda on Saturday chaired a CEO roundtable at India Medical Device 2026, bringing together government policymakers and more than 40 CEOs from global and domestic medical technology companies and MSMEs to discuss strengthening India’s.

• The report notes that India has developed important foundations for AI leadership through initiatives such as the Ayushman Bharat Digital Mission (ABDM), IndiaAI Mission, SAHI, BODH and the National Medical Devices Policy, 2023.

• With the convergence of digital infrastructure, artificial intelligence and a growing domestic medical device manufacturing base, the discussions at India Medical Device 2026 underscored the government’s push to position India as a competitive and.

Key Details

However, it says the ecosystem needs further development to enable AI technologies to scale across the healthcare system. Among the major challenges identified are fragmented health data, limited clinical evidence, evolving regulatory requirements and inadequate reimbursement pathways.

• The knowledge paper underlined that coordinated action among the government, regulators, healthcare providers, payers, industry and academia will be essential for India to move from experimentation to large-scale, responsible deployment of AI in healthcare.

• The event brought together senior officials from the Departments of Pharmaceuticals, Health Research, Health and Family Welfare and Promotion of Industry and Internal Trade, along with representatives of NITI Aayog, the National Health Authority.

• The discussions also focused on creating conditions that would enable Indian medical device companies to expand their global footprint.

Why It Matters

The report calls for India to move beyond successful AI pilots and enable routine clinical adoption by developing AI-ready data and evidence, lifecycle-based regulation and procurement and reimbursement mechanisms that recognise the value generated by AI-enabled technologies. AI-enabled diagnostics are expected to.

• The CEO roundtable provided a platform for senior government officials and industry leaders to discuss ways to strengthen India’s medical device ecosystem, promote investment and innovation and enhance domestic manufacturing capabilities.

• The discussion highlighted the need for credible clinical evidence, transparent HTA processes, realistic pricing, sustainable reimbursement mechanisms, greater involvement of clinicians and stronger training systems to facilitate wider adoption of innovative technologies.

What Reports Say

Coverage of the story so far points to:

• Continued reporting by DD India as more details emerge